Company / Gross Margin
Xtant Medical Holdings, Inc. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
58.2%
FY2025
5-year range
55.4% / 64.5%
FY2021-FY2025
Trend
-4.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 10 years, ranging from 55.4% in FY2023 to 69.2% in FY2017.
Based on SEC 10-K filings.
58.2% in FY2025 with a 5-year CAGR of -7.6%.
Improved from 55.4% to 58.2% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -0.6pp
- 5-Year Change
- -7.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 4.2% year-over-year.
- Peak gross margin was recorded in FY2017.
- Lowest gross margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 58.2% | -4.2% |
| FY2024 | 60.8% | +9.6% |
| FY2023 | 55.4% | -5.7% |
| FY2022 | 58.8% | -8.8% |
| FY2021 | 64.5% | -1.9% |
| FY2020 | 65.7% | +9.1% |
| FY2019 | 60.2% | -0.7% |
| FY2018 | 60.7% | -12.4% |
| FY2017 | 69.2% | +5.1% |
| FY2016 | 65.9% | +4.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026